Satellos Bioscience Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $9.8M | $40.1M | $16.7M |
| Accounts Receivable | — | — | — |
| Inventory | — | — | — |
| Total Current Assets | $31.9M | $50.7M | $30.5M |
| Property, Plant & Equipment | — | — | — |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $31.9M | $50.7M | $33.5M |
| Liabilities | |||
| Accounts Payable | $4.1M | $3.6M | $2.7M |
| Total Current Liabilities | $4.1M | $3.6M | $2.7M |
| Long-Term Debt | — | — | — |
| Total Liabilities | $4.1M | $3.6M | $2.7M |
| Stockholders' Equity | |||
| Retained Earnings | $-82.0M | $-57.1M | $-36.5M |
| Total Stockholders' Equity | $27.8M | $47.2M | $30.8M |